Prevalence of symptomatic androgen deficiency in men

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 11, 2007, Pages 4241-4247

  Araujo, Andre B ^a   Esche, Gretchen R ^a   Kupelian, Varant ^a   O'Donnell, Amy B ^a   Travison, Thomas G ^a   Williams, Rachel E ^b   Clark, Richard V ^b   McKinlay, John B ^a  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AFRICAN AMERICAN; AGE; AGED; AGING; ANDROGEN DEFICIENCY; ARTICLE; CONFIDENCE INTERVAL; DEPRESSION; ERECTILE DYSFUNCTION; EUROPEAN AMERICAN; FRACTURE; HISPANIC; HUMAN; LETHARGY; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; SLEEP DISORDER; SYMPTOM; TESTOSTERONE BLOOD LEVEL; UNITED STATES; WEAKNESS;

EID: 35948996162     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1245     Document Type: Article

References (43)

1. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB 2002 Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 87:589-598
2. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR 2001 Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86:724-731
3. Kaufman JM, Vermeulen A 1997 Declining gonadal function in elderly men. Baillieres Clin Endocrinol Metab 11:289-309
4. Zmuda JM, Cauley JA, Kriska A, Glynn NW, Gutai JP, Kuller LH 1997 Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol 146:609-617
5. Liverman CT, Blazer DG, eds 2004 Testosterone and aging: clinical research directions. Washington D.C.; The National Academies Press
6. Kaufman JM, Vermeulen A 2005 The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833-876
7. Derby CA, Zilber S, Brambilla D, Morales KH, McKinlay JB 2006 Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 65:125-131
8. Mohr BA, Bhasin S, Link CL, O'Donnell AB, McKinlay JB 2006 The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study. Eur J Endocrinol 155:443-452
9. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT 2004 Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27:1036-1041
10. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB 2000 Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts Male Aging Study. Diabetes Care 23:490-494
11. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB 2006 Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91:843-850
12. Orwoll E, Lambert LC, Marshall LM, Phipps K, Blank J, Barrett-Connor E, Cauley J, Ensrud K, Cummings S 2006 Testosterone and estradiol among older men. J Clin Endocrinol Metab 91:1336-1344
13. Handelsman DJ, Zajac JD 2004 11: Androgen deficiency and replacement therapy in men. Med J Aust 180:529-535
14. Matsumoto AM 2002 Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 57:M76-M99
15. Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang C, Weidner W, Wu FC 2005 Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl 28:125-127
16. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM 2006 Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91:1995-2010
17. Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM, McKinlay JB 2004 Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 89:5920-5926
18. Travison TG, Araujo AB, O'Donnell AB, Kupelian V, McKinlay JB 2007 A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab 92:196-202
19. McKinlay JB, Link CL 2007 Measuring the urologic iceberg: design and implementation of the Boston Area Community Health (BACH) Survey. Eur Urol 52:389-396
20. Bremner WJ, Vitiello MV, Prinz PN 1983 Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 56:1278-1281
21. Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD 2003 Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf) 58:710-717
22. Brambilla DJ, McKinlay SM, McKinlay JB, Weiss SR, Johannes CB, Crawford SL, Longcope C 1996 Does collecting repeated blood samples from each subject improve the precision of estimated steroid hormone levels? J Clin Epidemiol 49:345-350
23. Södergard R, Backstrom T, Shanbhag V, Carstensen H 1982 Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J Steroid Biochem 16:801-810
24. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672
25. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A 1997 The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49:822-830
26. Ware Jr J, Kosinski M, Keller SD 1996 A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220-233
27. Litman HJ, Bhasin S, Link CL, Araujo AB, McKinlay JB 2006 Serum androgen levels in black, Hispanic, and white men. J Clin Endocrinol Metab 91:4326-4334
28. Wu FC 2007 Commentary: Guideline for male testosterone therapy: a European perspective. J Clin Endocrinol Metab 92:418-419
29. Heinemann LAJ, Zimmermann T, Vermeulen A, Thiel C 1999 A new "Aging Male's Symptoms" (AMS) rating scale. Aging Male 2:105-114
30. Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, Perry 3rd HM 2000 Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 49:1239-1242.
31. Smith KW, Feldman HA, McKinlay JB 2000 Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocrinol (Oxf) 53:703-711
32. Zitzmann M, Faber S, Nieschlag E 2006 Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 91:4335-4343
33. Travison TG, Morley JE, Araujo AB, O'Donnell AB, McKinlay JB 2006 The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab 91:2509-2513
34. Kelleher S, Conway AJ, Handelsman DJ 2004 Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 89:3813-3817
35. Zitzmann M, Gromoll J, Nieschlag E 2005 The androgen receptor CAG repeat polymorphism. Andrologia 37:216
36. Zitzmann M, Nieschlag E 2003 The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl 26:76-83
37. Wong SY, Chan DC, Hong A, Woo J 2006 Prevalence of and risk factors for androgen deficiency in middle-aged men in Hong Kong. Metabolism 55:1488-1494
38. Kapoor D, Aldred H, Clark S, Channer KS, Jones TH 2007 Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care 30:911-917
39. Tan RS, Pu SJ 2002 Impact of obesity on hypogonadism in the andropause. Int J Androl 25:195-201
40. Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, Lacroix I, Somma-Delpero C, Boudou P 2003 Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem 49:1381-1395
41. Wang C, Catlin DH, Demers LM, Starcevic B, Swerdloff RS 2004 Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 89:534-543
42. Araujo AB, Travison TG, Harris SS, Holick MF, Turner AK, McKinlay JB 2007 Race/ethnic differences in bone mineral density in men. Osteoporos Int 18:943-953
43. Hastie TJ, Tibshirani RJ 1990 Generalized additive models. Boca Raton; Chapman, Hall/CRC